Ignite Creation Date:
2024-05-06 @ 6:43 PM
Last Modification Date:
2024-10-26 @ 2:53 PM
Study NCT ID:
NCT05765812
Status:
RECRUITING
Last Update Posted:
2024-04-24
First Post:
2023-02-15
Brief Title:
A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
Sponsor:
Debiopharm International SA
Organization:
Debiopharm International SA
Organization Data
Organization:
Debiopharm International SA
Class:
INDUSTRY
Study ID:
Debio 0123-GBM-105
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Debiopharm International SA
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None